BACKGROUND: Untargeted mass spectrometry (MS)-based metabolomics data often contain missing 35 values that reduce statistical power and can introduce bias in epidemiological studies. However, a 36 systematic assessment of the various sources of missing values and strategies to handle these data 37 has received little attention. Missing data can occur systematically, e.g. from run day-dependent 38 effects due to limits of detection (LOD); or it can be random as, for instance, a consequence of 39 sample preparation. 40
Introduction

69
In epidemiological studies, metabolomics is an established tool that provides insights into disease 70 mechanisms (1), as metabolite profiles generate a molecular readout that is closely linked to the 71 (patho-)phenotype (2,3). Recent metabolomics studies have identified many metabolites as 72 candidate biomarkers for various health conditions, such as diabetes (4-6) and cardiovascular 73 diseases (7, 8) . Mass spectrometry (MS)-based metabolomics measurements can be performed either 74 in a targeted or untargeted manner (9). In the former, only a limited number of already known and 75 biochemically annotated metabolites are captured. In the latter, the measurements are not limited 76 to predefined signals and offer discovery of novel compounds. While missing values in targeted MS-77 based data occur rarely, untargeted MS-based techniques typically produce 20-30% missing values, 78 affecting more than 80% of the measured compounds (10-13). 79
There are various reasons why metabolite concentrations can be missing in an untargeted 80 metabolomics dataset. First, it is possible that the molecules are truly absent from the sample, a 81 situation that may occur e.g. for drug metabolites that only appear in a subset of people taking that 82 medication. On the other hand, there are several technical reasons that could result in missing 83 values, including: (i) instrument sensitivity thresholds, below which concentrations of a specific 84 metabolite might not be detectable in a sample (i.e., below the limit of detection, LOD); (ii) matrix 85 effects that impede the quantification of a metabolite in a sample through other co-eluting 86 compounds and ion suppression; (iii) declining separation ability of the chromatographic column and 87 increasing contamination of the MS instrument; and (iv) limitations in computational processing of 88 spectra, such as poor selection and alignment of the spectral peaks across samples (14) . 89
Commonly, observed patterns of missing data are categorized as either missing completely at 90 random (MCAR), missing at random (MAR), or missing but not at random (MNAR) (15). In the MCAR 91 category, the probability of missing values does not depend on observed or unobserved 92 measurements. In contrast, the occurrence of MAR depends on other observed measurements (for 93 instance, resulting from technical effects, such as overlapping peaks). MNAR describes the 94 occurrence of missing values that depend on unobserved measurements (for instance, due to issues 95 with the performance of the machine). 96
Although it is clear that the handling of missing values affects all downstream analyses, it is 97 less clear how to appropriately handle their occurrence statistically. A simple ad hoc approach is 98 known as complete case analysis (CCA), which only considers samples that do not contain any missing 99 values in the metabolites analyzed in each statistical analysis step. However, missing data may occur 100 in some systematic way (i.e., they are dependent on external factors). For example, if all cases in a 101 case-control study have more missing data than the controls, removing observations that are missing 102 will lead to bias in biological interpretation (16) . Furthermore, CCA can cause severe loss of 103 information and statistical power by excluding a majority of observations if multivariate methods, 104 such as principal component analysis or partial correlation networks, are to be performed. 105
A widely used and flexible class of missing data strategies is imputation, which involves the 106 replacement of missing values by reasonable substitute values. The most commonly used imputation 107 approaches for metabolomics data assume that missing data occur because they are below the limit 108 of detection (left-censoring, a variant of MNAR). Therefore, all missing entries of a metabolite are 109 replaced by a low constant value, such as the actual LOD (if known), zero, or the smallest value found 110 in the dataset for that metabolite (13). Another LOD-based substitution strategy assumes a 111 parametric left-truncated normal distribution and performs likelihood-based parameter estimation 112 on the observed values to reconstruct the truncated part of the distribution. Missing values are then 113 replaced by numbers drawn from this estimated part (16, 17) . Additional imputation-based 114 substitution approaches assume MCAR and replace missing values by the mean or median per 115 metabolite (12). Advanced approaches use multivariate statistical methods for imputation, including 116 multiple imputation by chained equations (MICE) (18) and K-nearest neighbors (KNN) imputation 117 (19, 20) . 118 Several previous studies have investigated the occurrence and effects of different strategies 119 for missing values in metabolomics data. Taylor et al. (21) reported that no single imputation method 120 was universally superior, but constant substitution methods consistently showed poor performance. 121 Gromski et al. (12) Finally, in a study by Hrydziuszko and Viant (11), a KNN-based imputation approach also 129 outperformed competing strategies in an investigation of direct infusion Fourier transform ion 130 cyclotron resonance (DI-FTICR) MS-based metabolomics data. 131
Despite these advances in our understanding of the effects of imputation on metabolomics 132 data analysis, several aspects have not been addressed by those previous studies. (i) A detailed 133 statistical description of the patterns of missing values in MS-based metabolomics data has not yet 134 been published. Most previous studies evaluated imputation strategies assuming only random or 135 LOD-based missing values without assessing whether this applies to real metabolomics datasets. In 136 particular, the influence of batch effects on the occurrence of missing values has not been 137 investigated in any study. If a cohort comprises a large number of samples, the MS runs usually are 138 spread across multiple days, which is known to influence metabolite measurements due to variation 139 in instrument sensitivity. Here, the LOD itself is also expected to vary across run days, an assumption 140 that has not been explicitly accounted for in any studies. (ii) In addition, a simulation framework that 141 reflects realistic data situations is needed to provide an unbiased evaluation of strategies for handling 142 missing values. Evaluation of previous studies has been biased in the sense that "complete" 143 measured data (created by excluding all variables with missing values) with artificially introduced 144 missing values were simulated, which most likely does not mirror realistic missing value patterns. (iii) 145
Finally, biological validation and biochemical interpretation of the data have not been addressed in 146 the majority of papers. Only Hrydziuszko et al. evaluated the ability of different imputation strategies 147 to preserve metabolic differences between biological groups, which then were related to KEGG 148 pathways (11). 149
In the present study, we analyzed patterns of missing data and evaluated the performance of 150 various imputation strategies for untargeted MS-based metabolomics data from serum samples of 151 the German Cooperative Health Research in the Region of Augsburg (KORA) F4 cohort. Data were 152 measured on a typical, widely used untargeted MS-based metabolomics platform (Metabolon, Inc., 153 USA) and should be representative of many untargeted population-scale metabolomics studies. The 154 study consisted of three steps: (i) We described and analyzed patterns of missing values and their 155 possible underlying mechanisms in a real untargeted metabolomics dataset. In particular, we 156 investigated the occurrence of missing values within and across batches of measurements. (ii) The 157 insights gained from these analyses were used to introduce realistic patterns of missing data into 158 simulated data. We applied 31 imputation methods to the datasets and evaluated them with respect 159 to their ability to achieve correct statistical estimates and hypothesis test results in various data 160 scenarios. (iii) Finally, the imputation methods were applied to real metabolomics data (KORA F4), 161 followed by two biologically-driven evaluation schemes. First, we assessed how accurately real 162 biochemical pathways were reconstructed in data-driven correlation networks inferred from the 163 imputed data. Second, we verified whether imputation led to a gain in statistical power, while 164 preserving effects of genetic variants on metabolite levels. The study workflow is visualized in Figure  165 1. 166
Results
167
Characterization of missing data patterns in KORA F4 untargeted metabolomics 168 data 169 We used an untargeted metabolomics dataset from the KORA F4 study, which was generated from 170 fasting serum samples measured on three platforms: LC/MS in both positive (LC/MS+) and negative 171 modes (LC/MS−), as well as a GC/MS platform. After log-transformation and outlier handling (see 172 Methods), 1757 samples and 516 metabolites were available for analysis. 173
The dataset contained 19.41% missing values, with 416 (80.6%) metabolites and all 174
observations showing at least one missing value. The majority (301) of these 416 metabolites had 175 fewer than 10% missing values ( Figure 2A ). For only 9.9% (51) of the metabolites, more than 70% of 176 the measurements were missing. The amount of missing values per observation ranged from 11.4% 177 to 32.2%, with an average of 19.6% ( Figure 2B ). 178
LOD-based missing values 179
For metabolomics data, a common assumption is that missing values occur because of low 180 concentrations that are below the limit of detection. To explore this assumption, we analyzed missing 181 values of a metabolite using a second, strongly correlated metabolite, which we term the auxiliary 182 metabolite. The auxiliary metabolite is defined as the metabolite with the highest correlation ( ) to 183 the given metabolite. Due to its strong correlation, we assume that insights into the pattern of 184 missing values of a metabolite can be gained from the corresponding non-missing observations of its 185 auxiliary metabolite. For example, assuming that metabolite A has missing values in certain 186 observations for which its auxiliary metabolite B has measurements. If these measurements in B are 187 low then a missing value in A most likely occurred because the actual concentrations were below the 188 LOD. We required a minimum correlation of = 0.3 for auxiliary metabolites, but other values gave 189 qualitatively similar results (File S1). 190
Overall, an auxiliary metabolite was available for 56.6% of the metabolites. Of those, 62.0% 191 showed a clear tendency for missing values to below the LOD (see Methods and File S1). An example 192 for a clear LOD-tendency is shown for 7-methylxanthine in Figure 2C . This compound is a metabolite 193 of caffeine metabolism that is correlated with 3-methylxanthine. The majority of observations with 194 missing data in 7-methylxanthine showed low values for 3-methylxanthine, indicating that the 7-195 methylxanthine values were most probably below the LOD. An example for a metabolite pair that 196 does not show an LOD-based missingness pattern is provided in Figure 2D investigated metabolites can be found in File S1. 204
Although the LOD-tendency was observed for many metabolites, there was no clear LOD threshold 205 separating missing and observed measurements across all metabolites ( Figure 2C ), which would have 206 been the case if LOD was the only underlying mechanism for missing data. Instead, the values of the 207 auxiliary metabolites with missing values in the investigated metabolites were spread broadly over a 208 range of lower values, indicating a blurred rather than a single fixed LOD for all metabolites. 209
Run day-dependent missing values 210
Batch (run day) effects also can drive systematic patterns of missing data due to daily variation in 211 instrument sensitivity. To examine whether missing data depended on overall run day quality, we 212 examined the amount of missing values per run day for each platform (LC/MS+, LC/MS-, or GC/MS). 213
Subsequently, we investigated whether metabolites were affected differently by runday quality. 214
The KORA F4 samples were measured on 53 run days with 34 samples on average per day. If 215 missing values were dependent on run day quality due to variation in instrument performance (e.g., 216
caused by LC or GC column decline), we would expect there to be some days for which samples 217 overall contained more ("bad" run day) or fewer ("good" run day) missing values compared with the 218 average. Indeed, we observed such "bad" and "good" run days for all three platforms ( Figure 3A) . 219
While the run day-specific amount of missing values tended to be correlated between LC/MS− and 220 LC/MS+ (correlation of the run day-specific median of missing values between the two platforms was 221 = 0.36), there was no correlation between LC/MS+/− and GC/MS. This suggests that changes in 222 instrument performance, rather than global effects (such as those that could originate from sample 223 preparation) were responsible for differences in run day quality. 224
Although there was an overall effect of run day quality on the pattern of missing values, we 225 observed considerable differences in the standard deviations (SD) of run day-specific missing values 226 for metabolites with the same amount of missing data ( Figure 3B ). This suggests that metabolites 227 were affected differently by run day quality. For example, the bile acid ursodeoxycholate (46% total 228 missing data) showed relatively low variation in run day missing data (SD = 0.12) (Figure 3Figure 3C) . 229
However, for gamma-glutamylisoleucine ( Figure 3D ), a metabolite with a similar total amount of 230 missing values (42%), the observed variation in missing data across run days was substantially larger 231 (SD = 0.22). 232
Run day-dependent LOD mechanism 233
The observed run day-dependent pattern of missing data, together with the blurred LOD-based 234 pattern, suggests that different run days may exhibit different LODs, which contributed to the blurred 235 global LOD effect. To verify this, we calculated the correlation between run day mean and run day 236 missingness for all metabolites. A histogram of the correlation coefficients is shown in Figure 4A . The 237 majority of metabolites displayed a strong tendency for negative correlations. An example for run 238 day-specific LODs is shown in Figure 4B -C: for 7-methylxanthine, the correlation of run day mean and 239 the run day-specific amount of missing values is = −0.68 ( Figure 4B ). Run days with low means 240 tended to have a higher amount of missing values ( Figure 4C ). Density plots for all metabolites before 241 and after run day normalization can be found in File S2. 242
243
Taken together, we observed that batch (run day) effects on the limit of detection can result in a 244 blurred LOD-effect after run day normalization, which can explain patterns of missing values in most, 245 but not all, metabolites. 246 247 Evaluation of imputation approaches in a simulation framework 248 As shown in the previous analyses, not all of the missing data in MS-based metabolomics studies can 249 be attributed to run day-dependent LOD-based missing data. Thus, the optimal imputation approach 250 should perform well across all possible patterns. We conducted a simulation study to compare 251 statistical estimates between imputed and complete data. We simulated incomplete data according 252 to the patterns of missing values observed in the real metabolomics data and imputed these data 253 using various imputation approaches. We then evaluated these approaches for recovering correct 254 statistical estimates after conducting correlation and regression analyses. 255
Simulation setup and evaluation criteria 256
We simulated six mechanisms for missing data derived from observations in the real data (see 257
Methods, File S3, and Figure 5A LOD-based and unsystematic missingness. Based on these 6 mechanisms, we created various 264 parameter scenarios resembling realistic conditions. For each scenario, we conducted 250 265 simulations to assess whether the imputation methods could reconstruct statistical estimates of 266 Pearson correlation, partial correlation, linear regression (results shown in File S3), and logistic 267 regression. To this end, we calculated type 1 error as the proportion of simulations in which a 268 significant estimate was obtained when the true correlation was equal to zero. In addition, we 269 calculated power as the proportion of significant estimates when the true correlation was unequal to 270 zero. We also estimated bias, which is shown in File S3. A detailed description of the simulation and 271 evaluation framework is also provided in File S3. 272
Missing data handling strategies 273
We applied 31 imputation approaches (see Figure 5F ; detailed descriptions in Methods and File S4) 274 on the simulated data. Some were adapted to account for run day-specific missing values. The 275 imputation approaches followed different concepts, which could have one of the following four 276 properties or combinations thereof: (i) approaches that explicitly assume LOD-based missing values, 277
(ii) approaches that consider run day-specific missing values, (iii) multivariate procedures using 278 correlations among variables, and (iv) multiple imputation (MI) strategies. The MI approaches usually 279 comprise imputation, analysis, and pooling steps. In the first step, the incomplete data are imputed 280 m times to produce m complete datasets. Subsequently, statistical analysis is performed on each of 281 the m complete datasets and then the m analyses are combined to one final result. 282
Simulation results 283
In the following, we evaluate the performance of the four imputation properties (i)-(iv) introduced imputation by truncated sampling (ITS)), showed inflated type 1 error rates and low power for both 289 correlation and regression analysis. This was expected for three reasons. First, for a data scenario 290 with run day-dependent probabilistic LOD-based missing values, these methods underestimate the 291 LOD for most of the rundays and replace missing entries by too low values ( Figure 6A ). Second, for a 292 data scenario with random missing values, they expectedly fail since the underlying assumption of an 293 LOD is not met ( Figure 6B ). Finally, min and RC impute a metabolite by replacing all of its missing 294 entries by a constant value, which substantially distorts the metabolite distribution (see File S5). 295
Property (ii): The LOD-based methods that take run days into account (RC-R, ITS-R) were 296 expected to perform well in a simulated data scenario with run day effects ( Figure 6A ). Unexpectedly, 297
we observed an inflated type 1 error rate and decreased power for all three statistical analyses 298 (Pearson correlation, partial correlation, and logistic regression). RC-R and ITS-R assume that the 299 observed values of a metabolite follow a truncated normal distribution, which is parametrized by 300 maximum likelihood estimation (MLE), in order to replace missing values with randomly drawn values 301 from the truncated part. The instability of MLE due to small sample sizes available within run days 302 could explain the poor performance of these approaches. The same poor performance was observed 303 for scenarios with a mixture of run day-dependent LOD-based and random missing values ( Figure 6C ). 304
For the dataset with only random missing values, LOD-or run day-based approaches showed the 305 expected strong reduction in power since here the underlying assumption of a truncated normal 306 distribution is false ( Figure 6B ). 307 Property (iii): Multivariate approaches (imputation based on chained equations (ICE) and 308 KNN-based imputation) take into consideration the correlation between variables or observations. 309 ICE approaches had high power, but an increased type 1 error rate when missing value proportions 310 increased ( Figure 6 ). KNN-based imputation on observations with variable pre-selection and K = 10 311 (KNN-obs-sel(10)) was one of the best performing methods with high power and an overall marginal 312 type 1 error rate, even for a high amount of missing values. The power for KNN-obs was also high, 313
but it showed high type 1 error rate and therefore a poor ability to correctly identify truly absent 314 associations. In contrast, KNN-vars had a low type 1 error rate, but decreased power, which became 315 more pronounced at higher amounts of missing values. termed MICE-avg) was performed on each imputed data, and comprised the pooling of the imputed 325 data with subsequent statistical analyses rather than pooling the statistical estimates after analysis. 326
This approach showed high power, but increased type 1 error rates, in particular for >30% missing 327 values. 328
Taken together, when considering all patterns of missing data and all evaluation criteria, 329 KNN-obs-sel(10) and MICE-norm were the most robust approaches. For higher amounts of missing 330 data (≥50%), MICE showed a strong decrease in power with marginal type 1 error, whereas KNN-obs-331 sel(10) had only slightly increased type 1 error rates with high power. 332 333 Evaluation of imputation approaches on real MS-based metabolomics data 334 We conducted a biological evaluation of all approaches using the metabolomics data from the KORA 335 F4 population study. An objective criterion for evaluation is challenging to construct, since the true 336 values underlying the missing ones are unknown. We devised two indirect tests that assessed 337 imputed values for biological validity. First, we assessed the ability of imputation methods to 338 statistically reconstruct biochemical pathways in metabolomics data. Second, we evaluated the gain 339 in statistical power while preserving the true effect size of genetic variants (SNPs) on metabolite 340 levels. 341
Evaluation based on pathway modularity 342
GGMs are based on partial correlations and reflect conditional dependencies in multivariate Gaussian 343 distributions (5, 22) . When applied to metabolomics data, they reconstruct a precise picture of the 344 metabolic network, showing a modular topology with respect to known pathways. In other words, 345 metabolites will tend to be correlated with other metabolites from the same biochemical pathway 346 (5,22,23). We used this pathway-based modularity in a metabolic network as a quality criterion to 347 indicate whether the imputation methods generally were capable of maintaining biochemically valid 348 edges. 349
Each imputation strategy was applied to the KORA F4 metabolomics data, and a GGM was 350 estimated for each obtained dataset. Subsequently, we used a priori pathway annotations from 351 Metabolon Inc., where each metabolite was assigned to one pathway (e.g., branched-chain amino 352 acids, lysolipids, xanthines) to calculate pathway-based modularity ( ), according to (22, 24) . This 353 measure reflects the ratio of metabolite correlations within versus across pathways. A high Q value 354 indicates a dense within-pathway correlation compared with cross-pathways. Variability was 355 estimated by bootstrap resampling (see Methods). 356
Across all datasets, we obtained modularity values ranging from 0.384 to 0.434 ( Figure 7A ). 357 Imputation methods that explicitly considered the LOD-based mechanism and their run day-specific 358 versions ( Figure 5 , property (ii)) did not outperform alternative approaches. Multivariate, single 359 imputation methods (property (iii)) yielded low values, except for KNN-obs-sel, which achieved the 360 overall third best result ( = 0.422 for K = 10) ( Figure 5 ). The performance of KNN-based imputation 361 methods strongly depended on the definition of neighbors (variables or observations) and on the 362 number of these neighbors (K). The MI procedures (property (iv)) MITS, MITS-R, and MICE-avg 363 performed poorly, whereas the networks generated on MICE imputed data showed the overall 364 highest modularity ( = 0.434 and = 0.424 for MICE-norm and MICE-pmm, respectively) ( Figure 5 ). 365
Overall, the three best performing approaches were MICE-norm, MICE-pmm, and KNN-obs-sel(10). 366
Evaluation based on metabolite-SNP associations 367
Using KORA F4 data (n = 1750), we determined the ability of imputation methods to gain statistical 368 power compared with complete case analysis (CCA, deleting samples with any missing values) while 369 preserving the effect of genetic variants on metabolite levels in human blood. For the evaluation, we 370 selected a set of metabolite-SNP associations from a previous genome wide association study 371 (GWAS) in the KORA F4 and TwinsUK cohorts, for which a functional connection between the gene 372 and the metabolite was biologically evident (Table S8 ) (25). For example, GOT2 (rs4784054), which 373 was associated with concentrations of phenyllactate, encoded an enzyme that catalyzes the 374 conversion of phenylalanine to phenylpyruvate, which is then converted to phenyllactate (25,26). 375
We investigated the gain in statistical power when using imputed datasets compared with 376 the power obtained with CCA for 18 of such metabolite-SNP pairs, where the metabolite had 377 between 10% and 70% missing values. Statistical power gain was calculated as the negative log10 of 378 the ratio of the p-values estimated for the imputed data to the p-values estimated for CCA in 379 corresponding linear regression models (detailed results in File S8 and Table S8 ). A high ratio 380
indicates greater power for imputed data. As a second evaluation criterion, we calculated the log2 381 absolute ratio of the effect sizes obtained from the regression models for imputed data and those 382 derived from CCA in KORA F4 (see Methods). A log2 ratio close to zero indicates that the imputation 383 method was able to preserve effect sizes, whereas imputations yielding a highly negative or positive 384 log2 ratios indicate underestimation or overestimation of the effect sizes, respectively. 385 Imputation with LOD-based methods (property (i)) yielded a gain in power for up to seven 386 genetic associations of the 14 metabolites (Figure 7Figure 7) . For two of these associations 387 (tetradecanedioate and SLCO1B1; and hexadecanedioate and SLCO1B1), effect sizes were 388 underestimated, and for the association between 1-methylurate and NAT2, the effect size was 389 overestimated across all methods, except for MITS-R. Run day-specific imputation methods (property 390 (ii)) performed well, with ITS-R yielding the highest number of associations (12) with greater 391 statistical power, of which seven showed effect sizes similar to effect sizes derived from CCA. The 392 best methods among multivariate approaches (property (iii) and (iv)) were MICE-avg-norm, KNN-obs-393 sel(10), and KNN-obs-sel(20), all three of which generated a gain in statistical power for 12 394 associations. These methods also showed good performance in preserving genetic effects and did not 395
show severe overestimation or underestimation of effect sizes. MICE-norm/-pmm/-adjR showed only 396 moderate performance with a power gain for seven associations. 397
In an additional analysis, we used results from the EPIC-Norfolk cohort with n = 10 634 398 subjects (27), to assess the ability of imputation methods to preserve effects of genetic variants on 399 metabolites. We hypothesized that the effect sizes would be estimated more accurately in this much 400 larger dataset, and effect sizes obtained with KORA F4 imputed data should approximate effect sizes 401 derived from EPIC-Norfolk. Overall, we observed that the majority of SNP-metabolite pairs showed 402 either an overestimation or an underestimation of effect sizes across all imputation methods. This 403 tendency might reflect differences between the cohorts KORA F4 and EPIC-Norfolk rather than 404 differences between imputation strategies (see detailed results in File S7 and Table S8 ). 405
Overall, for nearly all metabolite-SNP pairs, this analysis showed that statistical power was 406 increased by imputing missing values and the effect sizes could be preserved. ITS-R, MICE-avg-pmm, 407 KNN-obs-sel with K = 10 and K = 20 were the imputation methods that generated the highest number 408 of associations (12) and resulted in a gain in statistical power compared with CCA. 409 410
Discussion
411
In this study, we investigated patterns of missing data in a typical example of untargeted MS-based 412 metabolomics data and their possible underlying mechanisms. Insights gained from these analyses 413 were used to generate simulated data that reflected the real data situation for a comprehensive 414 evaluation of 31 imputation methods. Finally, we applied the imputation strategies to real MS-based 415 metabolomics data from the German KORA F4 study and evaluated them using biological validity 416
measures. 417
For metabolomics data, an intuitive assumption is that missing data occur when metabolite 418 concentrations fall below the machine's LOD. Indeed, we found evidence for systematic patterns of 419 missing data due to LOD-and batch-effects for a large proportion of the analyzed metabolites. 420
Missing data were found to be influenced by run day quality, although metabolites varied in their 421 susceptibility to this effect. Finally, we found a negative correlation between run day mean and 422 missing data per run day, further confirming LOD-based mechanism within run days. The existence of 423 multiple run day-dependent LODs possibly accounted for the blurred rather than fixed global LOD 424 observed in the data. It has been suspected that multiple detection limits arise from factors such as 425 batch (run day) effects (27). However, to the best of our knowledge, this is the first time that these 426 effects have been systematically explored so far. 427
We evaluated 31 imputation methods in an evaluation framework consisting of three 428 schemes: (i) unbiased estimation of statistical estimates and hypothesis test results based on 429 simulated data, (ii) statistical reconstruction of biochemical pathways in metabolic networks, and (iii) 430 the ability to preserve effects of genetic variants on metabolite levels while allowing for a gain in 431 statistical power. 432 MICE-norm was the best performing imputation method for evaluation scheme (i) and (ii), but it 433 showed only moderate performances in the metabolite-SNP analysis. One major drawback of this 434 method is that multiple imputations have to be performed, making these approaches statistically and 435 computationally challenging. For m imputations, the desired statistical analyses must be performed 436 on each of the m imputed datasets, and then the resulting m estimates must be combined to one 437 statistical result. A widely applied alternative is to perform m multiple imputations and then combine 438 the m complete datasets to one final dataset containing the average of the imputed values (MICE-439 avg). That is, MICE-avg does not require statistical estimates to be pooled, and therefore, it is much 440 easier to apply. However, this simplicity is accompanied by an underestimation of metabolites' 441 variances, resulting in poorer performance of statistical estimation (correlation and regression 442 coefficients) and reconstruction of biochemical pathways. 443 A feasible, but better performing method was KNN-obs-sel(10), which uses KNN-based 444 imputation on observations with variable pre-selection and K = 10. This method ranked highly in all 445 evaluation schemes. Other KNN-based imputation schemes, including KNN-based imputation on 446 variables (KNN-vars) and on observations without variable pre-selection (KNN-obs), consistently 447 showed poor performance across all evaluation schemes. Our results are in line with observations 448 from previous studies, where KNN-based imputation performed well (10,11,15,28). However, we also 449 observed that variations of KNN imputation lead to substantially different results, as in previous 450 studies (20,28). 451
Although we observed LOD-and run day-based effects in real metabolomics data, methods 452 that explicitly consider this information did not outperform competing approaches in the first two 453 evaluation schemes. This is likely due to the fact that they perform imputation in a univariate manner 454 without taking the correlation between the variables into account. Moreover, all of these LOD-based 455 methods include maximum likelihood estimation in their imputation process, which was found to 456 perform well only for larger sample sizes in previous studies (27, 29) . In our study, the number of 457 observations within run days is limited, resulting in considerable instability of the MLE. LOD-based 458 run day-dependent methods performed well with respect to gain in statistical power in the analysis 459 of metabolites-SNP associations. 460
In summary, we have presented a detailed description of patterns of missing data in 461 untargeted MS-based metabolomics data. In particular, we considered, for the first time, the effects 462 of run days on systematic patterns of missing data. Our work showed that missing data occur in most 463 cases due to LOD effects, which are moreover run day-dependent. Nevertheless, MICE and KNN-464 based imputation, methods that do not explicitly consider LOD-based effects, performed best when 465 tested in both statistical and biological evaluation schemes. This is most likely because these 466 methods take into account multivariate dependencies within the data. The two approaches are For 467 future studies, we recommend KNN-based imputation on observations with K = 10, since it 468 consistently performed well across all data scenarios and all evaluation schemes, and is 469 computationally non-demanding for daily data analysis. Table S9 . For correlation 485 analysis, data were normalized for run day-effects by dividing each metabolite by run day median. 486
Since metabolite measurements were assumed to follow a log-normal distribution, the data were 487 log-transformed for all statistical analyses. The run day-corrected and log-transformed data were 488 used to determine outlier samples. Eleven individuals with a Mahalanobis distance (calculated across 489 the complete dataset) greater than four SD from the mean were considered outliers and excluded 490 from the dataset. For the biological evaluation schemes, age, sex, and BMI were used as standard 491 covariates. Seven samples were excluded due to incomplete information in these phenotypes, 492 resulting in 1750 individuals in total. 493
The KORA F4 cohort was genotyped using the Affymetrix Axiom platform. After quality 494 control, genotype data (measured or imputed according to data from the 1000 genomes project, 495 phase 1 version 3) were available for 1685 of the 1750 individuals. 496
Missing data in KORA F4
497
To explore the mechanism for the missing data of a given metabolite , a second (auxiliary) 498 metabolite was used. was defined as the metabolite with the strongest Pearson 499 correlation to (at least 0.3). An LOD-tendency was assumed if the average value of in 500 samples with missing values in was significantly lower than the average of in samples with 501 measured values in . Significance was assessed using Wilcoxon-Mann-Whitney tests with = 0.05 502 after Bonferroni correction for multiple testing. 503
For all correlation analyses, only metabolites with more than 10% and less than 70% overall 504 missing values were considered. 505
In order to explore whether missing values varied among run days, the normalized 506 proportions of missing values among the 53 run days were compared within each platform. For a 507 metabolite and a run day , the normalized amount of run day-specific missing values was 508 calculated as the number of missing values for in divided by the total number of samples 509 measured in , divided by the median value of missing data of over all run days. 510
Simulation study 511 Insights gained from the analyses of missing values in real MS-based metabolomics data were used to 512 create artificial data that best mirror reflected patterns of missing data. A brief overview of the 513 simulation framework is provided below, and a detailed description can be found in File S3. For each 514 set of parameters corresponding to a certain data situation, 250 random datasets were generated. 515
For each dataset, two variables were simulated by drawing from a multivariate normal distribution, 516 with sample sizes ranging from 100 to 1000, and with means equal to zero and covariance chosen 517 such that variances were equal to one (representing scaled variables). The Pearson correlation 518 between the two variables was ranged from 0 to 0.4. In addition, for the multivariate analyses and to 519 evaluate imputation methods that apply to a multivariate strategy, auxiliary variables correlated with 520 the two main variables were introduced. Their number and correlation strength were chosen to 521 match the real data (for details, see File S3). 522
Simulated observations were randomly assigned to "run days" with the number of run days 523 chosen such that each run day comprised 34 observations, according to the average number found 524 for the real KORA F4 measurements. 525 A proportion of missing values (10%, 30%, 50%, and 70%) was introduced into the main 526 variable pair according to different mechanisms derived from our observations in the KORA F4 527 Metabolon data ( Figure 5, File S3) . 528
We used the following parameter settings for the results in the main manuscript: moderate 529 variability of missing data across run days (see File S3), uncorrelated run day-specific missing patterns 530 of the metabolite pair, and varying association of the inverse relation between metabolite 531 concentration and missing values, at = 250 and in the presence of informative auxiliary 532 metabolites. For Pearson and partial correlation analysis, both main variables had the same degree of 533 missing data. For logistic regression analysis, the predictor variable had a mixture of 50% run day-534 dependent probabilistic LOD-based missing data and 50% non-systematic missing data. Results for 535 more parameter settings can be found in File S5. 536
Imputation approaches
537
A variety of imputation methods (Figure 5Figure 5) were selected because they were reported in the 538 context of metabolomics data or were developed and adopted to address characteristics in the 539 current dataset. (KNN-var(K)/KNN-obs(K)/KNN-obs-sel(K) ): In KNN-var and KNN-obs, missing values of 573 each variable are replaced by the weighted average of pre-specified K nearest variables and 574 observations, respectively. Distances to neighbors were defined as Euclidean distance and weights 575 were chosen as − , where defines the distances between two variables or observations. In KNN-576 obs-sel, KNN-obs is performed by selecting the strongest correlated variables with | | ≥ 0.2, but it 577 was constrained to a minimum of 5 and a maximum of 10 variables. The number of neighbors for K 578 was set to 3, 5, 10, and 20. 579
More detailed descriptions of RC, RC-R, ITS, MITS, ICE, and KNN-based methods can be found in File 580 S4. The two best performing methods, KNN-obs-sel(K) and MICE are available as R code in File S11. 581
Statistical evaluation of missing data handling strategies in the simulation study 582 Pearson correlation, partial correlation, linear regression, and logistic regression analysis were 583 performed, and the ability of imputation methods to reconstruct true associations and unbiased 584 hypothesis test results was evaluated. For logistic regression, a dichotomized variable was simulated 585 by discretizing one of the simulated continuous variables: all values above the median were set to 1 586
and all values below the median were set to 0. This dichotomized variable was used as response and 587 the remaining continuous variable as predictor. For MI strategies, the resulting (correlation or 588 regression coefficient) estimates and their variances were combined using Rubin's rules. The 589 obtained point estimates were then compared with the true underlying values by assessing the 590 validity of hypothesis tests. To this end, type 1 error was calculated as the proportion of significant 591 estimates (at α= 0.05) after imputation when there was no true effect. Power was calculated as the 592 proportion of significant estimates (at α= 0.05) after imputation in the presence of a true effect. 593
Detailed results can be found in File S5. 594 Evaluation based on pathway modularity 595 This analysis was based on pathway annotations from Metabolon Inc. (see Supporting Information 596 S9). Each imputation strategy was applied to the KORA F4 metabolomics data, resulting in different 597 imputed datasets. All unknown metabolites were excluded since these compounds were not assigned 598 to a pathway. For each imputed dataset, a Gaussian graphical model (GGM) was estimated to infer a 599 network using the R package GeneNet, version 1.2.12. In previous studies, we have demonstrated 600 that these models correctly reconstruct biochemical pathways from the data (22,25,37). In the case 601 of MIs, a GGM was estimated for each imputed dataset, followed by combining partial correlations 602 using Rubin's rules after a Fisher Z-transformation. The network was constructed using partial 603 correlations that are significantly different from zero after Bonferroni correction for * ( − 1)/2, 604
where is the number of metabolites. 605
The pathway-based network modularity measure (22,24) was calculated for each network as 606
where | | is the total number of pathways, is the set of all metabolites, and describes the subset 608 of metabolites annotated with pathway . ( , ) is the number of edges between any two node 609 sets and . The variance of was estimated non-parametrically using bootstrapping of the 610 original dataset (R package boot, version 1.3-15) with 1000 runs. 611
Evaluation based on metabolite-SNP associations 612
Linear regression was performed using KORA F4 CCA and the results were compared with each other. 613
For this analysis, we selected metabolite-SNP pairs for which (i) a genome-wide significant 614 association could be identified in the meta-analysis of KORA F4 and TwinsUK cohorts in a previous 615 GWAS (25) (summary statistics retrieved from http://www.gwas.eu); (ii) the proportion of each 616 metabolite's missing values in KORA F4 was between 10% and 70%; (iii) the metabolite was 617 measured in the EPIC-Norfolk cohort, which we used to further benchmark the preservation of effect 618 sizes; and (iv) a functional connection between the genetic locus of the SNP and the metabolite (e.g., 619
metabolite is a known substrate of the transporter) was evident according to manual curation of the 620 GWAS results (Table S8 ). For each imputed dataset, 18 metabolite-SNP pairs were tested for genetic 621 association using age-and sex-corrected linear regression models under the assumption of an 622 additive genetic model (metabolite ~ 0 + 1 × SNP + 2 × age + 3 × sex). To avoid spurious 623 associations, metabolic data points greater than four SDs from the mean were removed prior to 624 computing linear models. For MI approaches, the regression coefficients were pooled using Rubin's 625 rules as provided by the R package mice, version 2.25. For each metabolite-SNP pair, the variance of 626 the regression coefficients and p-values were estimated using bootstrapping. 627
To explore which imputation approaches increased statistical power, p-values obtained for 628 the effect sizes based on imputed data were compared with p-values obtained from CCA by 629 calculating their ratio as = − log 10 ( ) − log 10 ( ) , where was the p-value obtained for imputed data 630 and was the p-value derived from CCA. A ratio less than or equal to zero indicated either no 631 power gain or a power loss, whereas a ratio greater than zero indicated a drop in p-value, which 632 suggested that statistical power increased when imputation was performed. 633
In addition to statistical power gain, the imputation approaches should be able to preserve 634 effect sizes compared to CCA. Standardized effect sizes obtained from the imputed data ( ) were 635 compared with standardized effect sizes estimated for CCA ( ) based on the KORA F4 data (n = 636 1750) and the EPIC-Norfolk data (n = 10 634), assuming estimates from the EPIC-Norfolk data to be 637 close to true effects. We calculated the ratio = log 2 (| |), with a low ratio indicating a similar 638 effect size between the imputed data and CCA. A highly negative or positive indicates an 639 Council (MC_PC_13048 and MC_UU_12015/1). 713
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